Related Experiment Video
Updated: Jul 20, 2026

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.5K
A Multidisciplinary Perspective on Breast Phyllodes Tumors: A Literature Review
Alexandru-Gratian Naum1, Andra-Mara Ursu2, Paloma Moisii3
1Department of Morpho-Functional Sciences (II), Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
Medicina (Kaunas, Lithuania)
|October 29, 2025
Summary
Phyllodes tumors are rare breast neoplasms classified by the WHO as benign, borderline, or malignant. Diagnosis and treatment of these leaf-like tumors require careful histopathological and imaging assessment.
Area of Science:
- Oncology
- Pathology
Background:
- Phyllodes tumors, also known as cystosarcoma phyllodes, are rare fibroepithelial neoplasms of the breast.
- They are characterized by leaf-like histological structures and classified by the WHO into benign, borderline, and malignant categories.
- These tumors represent 0.3% to 1% of all breast tumors, with peak incidence in women aged 40-52.
Purpose of the Study:
- To review the classification, diagnosis, and treatment of breast phyllodes tumors.
- To highlight the importance of histopathological and imaging modalities in managing these rare neoplasms.
Main Methods:
- Review of current literature on phyllodes tumors.
- Analysis of diagnostic criteria including imaging (mammography, ultrasound, MRI) and histopathology (cellularity, mitotic activity).
- Discussion of immunohistochemical markers (Ki-67, p53) and treatment strategies.
Main Results:
- Phyllodes tumors exhibit diverse histopathological features influencing their categorization.
- Imaging and histopathology are crucial for diagnosis, categorization, and prognosis.
- Complete surgical excision with adequate margins is the primary treatment; adjuvant therapies like radiotherapy are debated.
Conclusions:
- Accurate diagnosis and categorization of phyllodes tumors are essential for effective management.
- Multidisciplinary approaches integrating imaging, histopathology, and clinical expertise are vital.
- Further research into adjuvant therapies may refine treatment protocols for malignant phyllodes tumors.
More Related Videos
Related Concept Videos
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

